Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 1/2 14Phase NA 10Phase 3 6Phase 1 4Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 3

Status

Unknown 3Recruiting 3

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Head & Neck 4Thoracic 2Other hematologic neoplasm 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Esophageal Neoplasms 2Stomach Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Hepatocellular 1Anus Neoplasms 1Anal Canal Carcinoma 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Radiation 24Panitumumab 24Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Immune Checkpoint Inhibitors × Gastrointestinal × Clear all
NCT06964568 2026-04-17

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Fudan University

Phase 3 Recruiting
452 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06086457 2024-07-16

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Recruiting
436 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT05737563 2024-01-23

Escape

Sun Yat-sen University

Phase 3 Unknown
380 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05374252 2022-05-16

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Unknown
102 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT04997837 2021-08-10

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma

Fudan University

Phase 3 Recruiting
433 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04229355 2021-02-09

DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma

Guangxi Medical University

Phase 3 Unknown
90 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡